Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements Of Operations

v3.25.3
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Condensed Consolidated Statements Of Operations [Abstract]        
Sales $ 18,993,636 $ 14,718,386 $ 44,694,528 $ 41,487,003
Cost of sales 11,781,951 9,482,661 28,212,001 26,653,476
Gross profit 7,211,685 5,235,725 16,482,527 14,833,527
Operating expenses:        
Selling, general and administrative expenses 6,898,041 6,133,087 19,381,068 19,321,037
Amortization expense 559,375 709,375 1,678,125 2,128,125
Fair value remeasurement of SUNation NY earnout consideration       (800,000)
Total operating expenses 7,457,416 6,842,462 21,059,193 20,649,162
Operating loss (245,731) (1,606,737) (4,576,666) (5,815,635)
Other (expense) income:        
Investment and other income 15,173 25,410 90,999 98,576
Gain on sale of assets   (6,940)   (822)
Fair value remeasurement of warrant liability   (1,435,845) (7,531,044) (974,823)
Fair value remeasurement of embedded derivative liability   587,271   (468,329)
Fair value remeasurement of contingent forward contract 789,588   899,080  
Fair value remeasurement of contingent value rights (2,318) (14,051) 23,132 478,809
Financing fees     (1,136,532)  
Interest expense (143,420) (811,551) (876,790) (2,312,054)
Loss on debt extinguishment   (35,657) (343,471) (35,657)
Other expense, net (130,565) (1,691,363) (8,874,626) (3,214,300)
Net loss before income taxes (376,296) (3,298,100) (13,451,292) (9,029,935)
Income tax expense 16,679 509 45,530 38
Net loss (392,975) (3,298,609) (13,496,822) (9,029,973)
Deemed dividend on extinguishment of Convertible Preferred Stock   (3,464,426)   (4,215,551)
Deemed dividend on modification of PIPE Warrants (875,737) (875,737)   (11,447,251)
Deemed contribution on exchange of equity instruments   4,075,681   4,075,681
Net loss attributable to common shareholders $ (392,975) $ (3,563,091) $ (13,496,822) $ (20,617,094)
Basic net loss per share [1] $ (0.12) $ (2,350.12) $ (6.19) $ (25,596.09)
Diluted net loss per share [1] $ (0.12) $ (2,350.12) $ (6.19) $ (25,596.09)
Weighted Average Basic Shares Outstanding [1] 3,406,614 1,516 2,180,066 805
Weighted Average Dilutive Shares Outstanding [1] 3,406,614 1,516 2,180,066 805
[1] Prior period results have been adjusted to reflect the reverse stock split of the common stock at a ratio of 1-for-200 that became effective April 21, 2025, the reverse stock split of the common stock at a ratio of 1-for-50 that became effective October 17, 2024 and the reverse stock split of the common stock at a ratio of 1-for-15 that became effective June 12, 2024. See Note 1, "Nature of Operations," for further details.